EFFECTS OF HUMAN CALPROTECTIN (L1) ON IN-VITRO IMMUNOGLOBULIN-SYNTHESIS

被引:37
作者
BRUN, JG
ULVESTAD, E
FAGERHOL, MK
JONSSON, R
机构
[1] GADE INST,DEPT MICROBIOL & IMMUNOL,BROEGELMANN RES LAB MICROBIOL,BERGEN,NORWAY
[2] UNIV BERGEN,CTR RHEUMATOL,BERGEN,NORWAY
[3] ULLEVAL UNIV HOSP,BLOOD BANK,OSLO,NORWAY
[4] ULLEVAL UNIV HOSP,DEPT IMMUNOL,OSLO,NORWAY
关键词
D O I
10.1111/j.1365-3083.1994.tb03523.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Calprotectin (L1) is a major cytoplasmic protein of neutrophilic granulocytes and monocytes/macrophages which is released from leucocytes during activation or cell death. Apart from in vitro antimicrobial and antiproliferative activity little is known about the biological function of the protein. Since previous investigations have shown that calprotectin plasma levels are elevated in various inflammatory rheumatic diseases, we wanted to investigate if calprotectin has an effect on immune cell functions. Peripheral blood mononuclear cells, either unstimulated or polyclonally stimulated with mitogen, were incubated with calprotectin and effects were assessed by enumeration of immunoglobulin secreting cells (ELISPOT). The results indicate that incubation with high concentrations of calprotectin (>64 mu g/ml) inhibit the production of the three classes of immunoglobulins investigated (IgG, IgM and IgA), both for mitogen stimulated and unstimulated lymphocytes. Except for the highest concentration of calprotectin (500 mu g/ml), it seems plausible that the observed inhibitory effect of calprotectin on Ig production is not a result of a direct toxic effect of calprotectin on B lymphocytes. Altogether, these effects of high calprotectin levels might be of importance in the immunoregulation of inflammatory conditions.
引用
收藏
页码:675 / 680
页数:6
相关论文
共 26 条
  • [1] THE LEUKOCYTE L1-PROTEIN - IDENTITY WITH THE CYSTIC-FIBROSIS ANTIGEN AND THE CALCIUM-BINDING MRP-8 AND MRP-14 MACROPHAGE COMPONENTS
    ANDERSSON, KB
    SLETTEN, K
    BERNTZEN, HB
    DALE, I
    BRANDTZAEG, P
    JELLUM, E
    FAGERHOL, MK
    [J]. SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1988, 28 (02) : 241 - 245
  • [2] BERATZEN HB, 1991, J RHEUMATOL, V18, P133
  • [3] Berntzen H B, 1988, Scand J Rheumatol Suppl, V76, P251
  • [4] THE LEUKOCYTE PROTEIN-L1 IN PLASMA AND SYNOVIAL-FLUID FROM PATIENTS WITH RHEUMATOID-ARTHRITIS AND OSTEOARTHRITIS
    BERNTZEN, HB
    OLMEZ, U
    FAGERHOL, MK
    MUNTHE, E
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 1991, 20 (02) : 74 - 82
  • [5] BERNTZEN HB, 1989, J RHEUMATOL, V16, P1416
  • [6] DISTRIBUTION OF MACROPHAGES AND GRANULOCYTES EXPRESSING L1 PROTEIN (CALPROTECTIN) IN HUMAN PEYERS-PATCHES COMPARED WITH NORMAL ILEAL LAMINA PROPRIA AND MESENTERIC LYMPH-NODES
    BJERKE, K
    HALSTENSEN, TS
    JAHNSEN, F
    PULFORD, K
    BRANDTZAEG, P
    [J]. GUT, 1993, 34 (10) : 1357 - 1363
  • [7] THE MOLECULAR NATURE OF THE CYSTIC-FIBROSIS ANTIGEN
    BRUGGEN, J
    TARCSAY, L
    CERLETTI, N
    ODINK, K
    RUTISHAUSER, M
    HOLLANDER, G
    SORG, C
    [J]. NATURE, 1988, 331 (6157) : 570 - 570
  • [8] BRUN JG, 1994, J RHEUMATOL, V21, P733
  • [9] BRUN JG, 1992, J RHEUMATOL, V19, P859
  • [10] A SOLID-PHASE ENZYME-LINKED IMMUNOSPOT (ELISPOT) ASSAY FOR ENUMERATION OF SPECIFIC ANTIBODY-SECRETING CELLS
    CZERKINSKY, CC
    NILSSON, LA
    NYGREN, H
    OUCHTERLONY, O
    TARKOWSKI, A
    [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1983, 65 (1-2) : 109 - 121